Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • FEATURED
  • Is Sputnik V coming into being for Covid-19?

Mankind is a click away from being in a clinical trial. Here’s How.

Novozymes Research Associate Job | Life Sciences | Apply Online

Is Sputnik V coming into being for Covid-19?
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

Is Sputnik V coming into being for Covid-19?

bioxone September 9, 2020September 9, 2020

–Shrestha Dutta, Amity University Kolkata

The premier batch of the ‘Gam-COVID-Vac’ [Sputnik V] immunization for the prevention of novel Coronavirus, created by the Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia, has finished the vital quality assessments in the labs of Roszdravnadzor. Russian Health Minister Mikhail Murashko had declared that immunization against COVID-19 among volunteers under stage 3 of clinical preliminaries will begin this week. Moscow Mayor hopes that a greater number of the Russian capital’s inhabitants would be immunized against COVID-19 inside a while.

Concurrently, the CEO of the Russian Direct Investment Fund (RDIF), on Monday affirmed that the clinical trial of the Sputnik V immunization will start this month in nations, including India. Russia had said that almost 20 nations, including the UAE, Saudi Arabia, Indonesia, Philippines, Mexico, Brazil, and India, have expressed their desire for acquiring the antibody following enlistment. The after-effects of the stage 1-2 clinical preliminaries, released in the medical journal The Lancet, indicated 100 percent of members developed antibodies to the SARS-CoV-2 infection with no genuine symptoms.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Covid Covid vaccine Russia Sputnik V

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • FEATURED
  • Job and Internship
  • Latest
  • Signaling Pathway

Novozymes Research Associate Job | Life Sciences | Apply Online

bioxone September 9, 2020

–Shristi Sharma, Team bioXone Candidates with a life science background can apply. Bengaluru job vacancy for MSc/MTech life science candidates for the post of  R&D post available at Novozymes. Check the details below: Job Title: Senior Research Associate, R&T, Bangalore, India Job ID: 7457BR Location: Bangalore Country: India Senior Research Associate, Bangalore, Molecular Biology as […]

Related Post

  • BiotechToday
  • World

Norovirus cases double: England warned by officials

BioTech Today July 27, 2021July 26, 2021

Mahek Sharan, Institute of Applied Medicines and Research, Ghaziabad Norovirus is responsible for the 200,000 deaths every year globally. It affects the population across the world including the developed or developing countries. The developed countries are more severely affected by norovirus, with a record of 50,000 deaths in the winter months. In a recent report […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

A vaccine to cure both yellow fever and COVID – 19?

bioxone December 7, 2020December 7, 2020

Prama Ghosh, Amity University Kolkata Based on the vaccine against yellow fever, a team of researchers led by Professor Johan Neyts and Kai Dallmeier at Rega Institute at KU Leuven, Belgium, have developed a vaccine candidate against Covid-19 which also works against yellow fever. Results indicate that the vaccine is effective in hamsters and monkeys […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Genetic biobank: a repository for the prevention of SIDS

BioTech Today July 8, 2021July 7, 2021

Arya Sukumar, College of Agriculture, Vellayani Groundbreaking research by the team of Professor Leanne Dibbens has formulated a genetic biobank that helps to identify the mechanisms involved in Sudden Infant Death Syndrome (SIDS) in newborn babies so that future work can stop SIDS from occurring. What is Sudden Infant Death Syndrome (SIDS)?                                                                       Sudden […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy